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From october 25th - 27th 2013, the 5th NEUROWIND e.V. meeting was held in Motzen, Brandenburg, Germany. This
year more than 60 doctoral students and postdocs from over 25 different groups working in German university
hospitals or research institutes attended the meeting to discuss their latest findings in the fields of neuroimmunology,
neurodegeneration and neurovascular research. All participants appreciated the stimulating environment in Motzen,
Brandenburg, and people took the opportunity for scientific exchange, discussion about ongoing projects and already
started further collaborations. Like in the previous years, the symposium was regarded as a very well organized platform
to support research of young investigators in Germany.
According to the major aim of NEUROWIND e.V. to support younger researchers in Germany the 3rd NEUROWIND
YOUNG SCIENTIST AWARD for experimental neurology was awarded to Ruth Stassart working in the group of Klaus Armin
Nave and Wolfgang Brück (MPI Göttingen and Department of Neuropathology, Göttingen Germany). The successful work
was published in Nature Neuroscience entitled “A role for Swann cell-derived neuregulin-1 in remyelination”. This outstanding
paper deals with the function of Schwann cell neuregulin as an endogenous factor for myelin repair. The award is
endowed with 20.000 Euro sponsored by Merck Serono GmbH, Darmstadt, Germany (unrestricted educational grant).
This year’s keynote lecture was given by Albert Ludolph, Head of the Department of Neurology at the University Clinic of
Ulm. Dr. Ludolph highlighted the particular role of individual scientists for the development of research concepts in
Alzheimer´s disease (AD) and frontotemporal dementia (FTD).Summary of the scientific contributions to the
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Contributions on vascular neurology
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stated.assays from stroke patients. Next, Gilla Lättig from the
group of Christoph Harms, Berlin, gave a talk on neuro-
protective effects by E2 factor mediated ORC-1 repression
in an oxygen glucose deprivation cell culture model. Peter
Ludewig from Tim Magnus` group studied the role of
carcinoembryonic antigen-related cell adhesion molecule 1
(CEACAM-1) in experimental stroke. Lack of CEACAM-1
increased infarct size, blood brain barrier breakdown as
well as edema formation, which was accompanied by
impaired neurologic outcome measures in the middle
cerebral artery occlusion (MCAO) model via effects on
granulocytes and MMP-9. Tian Zhang from Andreas
Meisel`s laboratory in Berlin focused on the effects oftd. This is an Open Access article distributed under the terms of the Creative
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clinical outcome in a murine MCAO stroke model. Robert
Brunkhorst (from Christian Förch`s group, Frankfurt)
talked about effects of the sphingosin-1 receptor modulator
fingolimod in the later phase after experimental cerebral
ischemia. Finally, Eva Göb from the group of Christoph
Kleinschnitz in Würzburg focused on the role of NADPH
oxidases (NOX) in models of focal cerebral ischemia.
She reported on stroke outcome in mice conditionally
deficient for NOX4 in endothelial or smooth muscle cells
thereby extending the already published data on constitu-
tive Nox4−/− mice.
Neuroimmunology and oligodendroglial biology
Felipe Ortega from Mainz gave a talk on Wnt signal-
ling pathways controlling distinct lineage commitment
of subependymal zone stem cells giving rise to either
oligodendroglial or neuronal cells. Next, Vasileia-Ismini
Alexaki from the group of Trian Chavakis, Dresden,
reported on the role of the tyrosine kinase receptor
TrkA and its ligand nerve growth factor as modulator
of microglia-mediated inflammation. Eva Tolosa from
Hamburg focused on regulatoy T cells (Treg) positive for
the cell surface marker CD39. These Treg may modulate
the ATP/adenosine axis in autoimmune diseases such as
multiple sclerosis (MS). Verena Schultz from the group of
Andreas Junker in Göttingen gave a presentation on the
role of the immunomodulatory surface molecule integrin
associated protein (CD47) during remyelination. They
studied the role of CD47 for processes of demyelination
in vivo (cuprizone model) and cell culture models of
myelination. Agnes Kovacs from the group of Ralf Linker,
Erlangen, talked about the role of alternative renin angio-
tensin (Ang) system signalling pathways including Ang1-7
and Mas in experimental autoimmune encephalomyelitis
(EAE). Next, Thomas Korn from Munich gave a presen-
tation on the consequences of VLA-4 blockade on the
function of different CD4+ positive T helper cell subsets
in a mouse model of acute viral encephalitis. Kerstin Berer
from Harmut Wekerle`s lab in Munich investigated the gut
microbiota as new trigger for CNS-specific autoimmunity.
Tobias Lanz from Michael Platten`s group in Heidelberg
presented data on the key role of protein kinase Cβ
pathways for blood brain barrier function in EAE. PKCβ
inhibitors like enzastaurin may prove to be promising
compounds for the treatment of neuroinflammation.
Focusing on CD8+ positive T cell antigen recognition, Eva
Reuter from the group of Volker Siffrin (Mainz) provided
data on in vivo imaging of cross recognition between OVA
and MOG in CD8 Tcells during EAE.
Bettina Trinschek from the Jonuleit laboratory in Mainz
talked about the role of IL-6 in the regulation of Treg
function in humanized mice and MS patients. The „early“
presence of IL-6 may induce resistance of effector Tcells towards Treg. At the end of the session, Benjamin
Schattling from Manuel Friese`s group in Hamburg pre-
sented work on the role of transient receptor potential
(TRP) ion channels in neuroinflammation. He focused on
transient receptor potential melastatin (TRPM) 4 cation
channels in neurodegeneration during EAE and TRPM2 in
the MCAO model of cerebral ischemia.
Neuroscience and neurodegeneration
Petra Hühnchen from the group of Wolfgang Böhmerle,
Berlin, reported on the behavioral, electrophysiological and
morphometric characterization of animal models of neuro-
pathic pain induced with different chemotherapeutics with a
focus on allodynia. Janos Groh from Rudolf Martini´s group
in Würzburg gave a talk on neurodegeneration and the role
of immune cells in the visual system of mouse models for in-
fantile and juvenile neuronal ceroid lipofuscinosis. Focusing
on peripheral innate immunity in Parkinon`s disease (PD),
Veselin Grozdanov from Karin Danzer`s group in Ulm re-
ported on cytokine profiles and function of isolated mono-
cytes from PD patients. In a talk on sporadic proteopathies
of the brain, Markus Krohn from Jens Pahnke`s group in
Magdeburg reported on the role of ABC transporters in
Alzheimer`s disease with a special focus on the effect of
ABCB1 and ABCC1 regarding clearance mechanisms. Judith
Alferink from the Department of Psychiatry in Münster
investigated APP/PS1 mice and presented data on the role
of CCL17 in neurodegeneration. CCL17 deficiency resulted
in beneficial microglia responses and rescued mice from
cognitive decline. Finally, Nadine Haase from Dominik
Müller`s group in Berlin provided a study on alpha1 adren-
ergic receptor (α1AR) and β-amyloid. Amyloid β peptides
may activate α1AR thus providing a possible link between
hypertension and Alzheimer`s disease.
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